Reaction

Smooth Muscle Cell Neoplasm reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 409 reports · 21 co-occurring drugs

As of the last recalculation, Smooth Muscle Cell Neoplasm appears in 409 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is GANCICLOVIR (PRR 729.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ganciclovir108729.3737.1
Ganciclovir Sodium108705.3712.6
Tacrolimus Ointment 0.1%325642.8644.5
Tacrolimus Extended-Release Capsules325641.1642.8
Tacrolimus330550.9552.1
Sirolimus90435.6438.5
Mycophenolate Mofetil290371.0371.8
Mycophenolate Mofetil Hydrochloride290370.4371.2
Valganciclovir Hydrochloride Powder,47221.4222.3
Valganciclovir57178.6179.2
Valganciclovir Hydrochloride57178.6179.2
Basiliximab25115.2115.4
Vincristine Sulfate4996.596.7
Cyclosporine10564.364.3
Human Immunoglobulin G2462.862.9
Doxorubicin Hydrochloride3355.955.9
Everolimus Tablets1340.740.7
Anti-Thymocyte Globulin (Rabbit)638.438.4
Mycophenilic Acid1538.238.2
Doxorubicin4830.930.9
Busulfan826.426.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.